Journal Article Summary
The article examines how artificial intelligence (AI) has contributed to the development of medicines for COVID-19, particularly through the repurposing of existing drugs. This topic is significant because the COVID-19 pandemic has created an urgent need for effective treatments, and AI offers a promising approach to quickly analyze vast amounts of data to identify potential therapeutic candidates. The study aims to systematically review the literature on AI's role in finding repurposed drugs that could be effective against COVID-19, highlighting the importance of innovative solutions in addressing public health crises.
The researchers conducted a systematic review using established guidelines to gather relevant studies from databases like PubMed and Cochrane Library. They identified 27 studies that explored various drug candidates, including antivirals, antibiotics, and anti-inflammatory medications, which were analyzed for their potential effectiveness against COVID-19. The findings suggest that AI can efficiently identify and evaluate existing drugs that may be repurposed for treating COVID-19, with several candidates showing promise based on in vitro and clinical data.
However, the review has limitations, such as the potential for selection bias since it was conducted by a single author and the limited number of databases used. Additionally, many studies lacked comprehensive in vitro or clinical findings, making it difficult to fully validate the effectiveness of the identified drugs. Patients and caregivers should discuss any interest in these repurposed drugs with healthcare professionals, especially since many candidates are still undergoing clinical trials and may not yet be proven safe or effective for COVID-19 treatment.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Pires Carla. A Systematic Review on the Contribution of Artificial Intelligence in the Development of Medicines for COVID-2019. Journal of Personalized Medicine 2021. DOI: 10.3390/jpm11090926. PMID: 34575703. PMCID: PMC8465965.
Featured Pill Pals Product
Azelastine Nasal Solution One Percent (1%) 30 ml --- Generic For Astelin --- 137 mcg --- 200 Metered Sprays --- Apotex Pharma
Azelastine Nasal Solution One Percent (1%) 30 ml — Generic For Astelin — 137 mcg — 200 Metered Sprays — Apotex Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
